Hikma Pharmaceuticals Plc Director/PDMR Shareholding (8614I)

TIDMHIK

RNS Number : 8614I

Hikma Pharmaceuticals Plc

13 August 2019

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Khalid Nabilsi

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Khalid Nabilsi 
 2    Reason for the notification 
 a)   Position/status           Chief Financial Officer 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             ID Code: GB00B0LCW083 
       instrument, type 
       of instrument 
       and identification 
       code 
 b)   Nature of the             Disposal of 45,000 Ordinary Shares of 10 pence 
       transaction               each in Hikma Pharmaceuticals PLC. 
 c)   Price(s) and              Price(s): GBP19.48 
       volume(s)                 Volume(s): 10,000 
                                 Price(s): GBP19.50 
                                 Volume(s): 5,000 
                                 Price(s): GBP19.79 
                                 Volume(s): 25,000 
                                 Price(s): GBP19.75 
                                 Volume(s): 5,000 
 d)   Aggregated information    Aggregated volume: 45,000 
                                 Price: GBP19.68 
                                 Total: GBP885,600 
 e)   Date of the transaction   9 and 12 August 2019 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Bassam Kanaan

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Bassam Kanaan 
 2    Reason for the notification 
 a)   Position/status           EVP, Corporate Development and M&A 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             ID Code: GB00B0LCW083 
       instrument, type 
       of instrument 
       and identification 
       code 
 b)   Nature of the             Disposal of 84,500 Ordinary Shares of 10 pence 
       transaction               each in Hikma Pharmaceuticals PLC. 
 c)   Price(s) and              Price(s): GBP19.47 
       volume(s)                 Volume(s): 15,000 
                                 Price(s): GBP19.72 
                                 Volume(s): 50,000 
                                 Price(s): GBP19.79 
                                 Volume(s): 5,000 
                                 Price(s): GBP19.72 
                                 Volume(s): 4,500 
                                 Price(s): GBP19.75 
                                 Volume(s): 5,000 
                                 Price(s): GBP19.70 
                                 Volume(s): 5,000 
 d)   Aggregated information    Aggregated volume: 84,500 
                                 Price: GBP19.68 
                                 Total: GBP1,662,990 
 e)   Date of the transaction   9 and 12 August 2019 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Peter Speirs, Company Secretary, Responsible for releasing this announcement

13 August 2019

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

DSHGCGDICBBBGCX

(END) Dow Jones Newswires

August 13, 2019 05:20 ET (09:20 GMT)